Suman Giri

Vice President, Head Of Data Science And Machine Learning at Pfizer

Suman Giri, PhD, currently serves as the Vice President and Head of Data Science and AI at Pfizer, a position held since 2024. Prior to joining Pfizer, Suman Giri was the Executive Director and Head of Data Science at Merck from 2021 to 2024. Earlier experience includes serving as the Director of Data Science & Consulting at CitiusTech, and as a Data Science Manager at Highmark Inc. Suman Giri's career also encompassed roles such as Data Scientist at Aetna, CTO and Strategy Advisor at EEme, LLC, and R&D researcher at Samsung Telecommunications America. Suman Giri holds a PhD in Advanced Infrastructure Systems from Carnegie Mellon University and a BA in Physics and Mathematics from Oberlin College.

Location

New York, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Pfizer

614 followers

Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.